538837 — Jeevan Scientific Technology Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Jeevan Scientific Technology, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	Interim Report	ARS	PRESS
Standards:	IAS	IAS	—	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	249	475	566	362	397
Cost of Revenue
Gross Profit	240	468	492	332	358
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	342	335	432	400	410
Operating Profit	-93.3	139	134	-37.8	-13.1
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-105	136	183	-36.8	-16
Provision for Income Taxes
Net Income After Taxes	-85.9	117	123	-30.6	-13.3
Minority Interest
Net Income Before Extraordinary Items
Net Income	-85.9	117	123	-30.6	-13
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-85.9	117	123	-30.6	-13
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-5.61	7.67	8.15	-1.98	-0.86
Dividends per Share